KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) FCF Margin: 2015-2025

Historic FCF Margin for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 25.10%.

  • BeOne Medicines' FCF Margin rose 1964.00% to 25.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.95%, marking a year-over-year increase of 4094.00%. This contributed to the annual value of -16.62% for FY2024, which is 5331.00% up from last year.
  • As of Q3 2025, BeOne Medicines' FCF Margin stood at 25.10%, which was up 47.79% from 16.98% recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' FCF Margin registered a high of 25.10% during Q3 2025, and its lowest value of -305.88% during Q2 2021.
  • In the last 3 years, BeOne Medicines' FCF Margin had a median value of -22.12% in 2024 and averaged -32.09%.
  • As far as peak fluctuations go, BeOne Medicines' FCF Margin soared by 72,122bps in 2021, and later slumped by 12,130bps in 2022.
  • Over the past 5 years, BeOne Medicines' FCF Margin (Quarterly) stood at 5.66% in 2021, then plummeted by 12,130bps to -115.64% in 2022, then spiked by 5,596bps to -59.68% in 2023, then soared by 5,814bps to -1.54% in 2024, then surged by 1,964bps to 25.10% in 2025.
  • Its FCF Margin was 25.10% in Q3 2025, compared to 16.98% in Q2 2025 and -1.43% in Q1 2025.